Endogenic and Iatrogenic Diabetes Mellitus in Drug-naïve Schizophrenia: The Role of Olanzapine and its Place in the Psychopharmacological Treatment Algorithm
Authors:
Open Access
- 15 September 2011
- journal article
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 36 (11) , 2368-2369
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysisSchizophrenia Research, 2010
- Antipsychotics Associated with the Development of Type 2 Diabetes in Antipsychotic-Naïve Schizophrenia PatientsNeuropsychopharmacology, 2010
- The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary StatementsSchizophrenia Bulletin, 2009
- The Danish National Diabetes Register: trends in incidence, prevalence and mortalityDiabetologia, 2008